JP6872758B2 - 動的光散乱（ｄｌｓ）による神経学的状態又は適合性状態の血行力学的特徴付けのための方法及び装置 - Google Patents
動的光散乱（ｄｌｓ）による神経学的状態又は適合性状態の血行力学的特徴付けのための方法及び装置 Download PDFInfo
- Publication number
- JP6872758B2 JP6872758B2 JP2018521537A JP2018521537A JP6872758B2 JP 6872758 B2 JP6872758 B2 JP 6872758B2 JP 2018521537 A JP2018521537 A JP 2018521537A JP 2018521537 A JP2018521537 A JP 2018521537A JP 6872758 B2 JP6872758 B2 JP 6872758B2
- Authority
- JP
- Japan
- Prior art keywords
- bsrd
- signal
- subject
- stress
- pulsatile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 184
- 238000002296 dynamic light scattering Methods 0.000 title description 58
- 230000000004 hemodynamic effect Effects 0.000 title description 15
- 230000000926 neurological effect Effects 0.000 title description 12
- 238000012512 characterization method Methods 0.000 title 1
- 230000000541 pulsatile effect Effects 0.000 claims description 224
- 230000004044 response Effects 0.000 claims description 138
- 230000003287 optical effect Effects 0.000 claims description 94
- 210000004369 blood Anatomy 0.000 claims description 83
- 239000008280 blood Substances 0.000 claims description 83
- 238000004458 analytical method Methods 0.000 claims description 74
- 230000036651 mood Effects 0.000 claims description 73
- 210000003743 erythrocyte Anatomy 0.000 claims description 61
- 230000036962 time dependent Effects 0.000 claims description 54
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 39
- 230000001427 coherent effect Effects 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 22
- 230000006399 behavior Effects 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 13
- 230000001114 myogenic effect Effects 0.000 claims description 12
- 238000009795 derivation Methods 0.000 claims description 11
- 230000001272 neurogenic effect Effects 0.000 claims description 11
- 238000011002 quantification Methods 0.000 claims description 11
- 238000004364 calculation method Methods 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 6
- 230000003542 behavioural effect Effects 0.000 claims description 4
- 238000010801 machine learning Methods 0.000 claims description 4
- 230000035882 stress Effects 0.000 description 282
- 230000002996 emotional effect Effects 0.000 description 43
- 230000000875 corresponding effect Effects 0.000 description 42
- 238000001228 spectrum Methods 0.000 description 36
- 230000017531 blood circulation Effects 0.000 description 35
- 210000002216 heart Anatomy 0.000 description 34
- 230000006870 function Effects 0.000 description 26
- 238000005259 measurement Methods 0.000 description 24
- 230000008451 emotion Effects 0.000 description 22
- 230000003340 mental effect Effects 0.000 description 22
- 210000004204 blood vessel Anatomy 0.000 description 21
- 238000004590 computer program Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 19
- 239000002245 particle Substances 0.000 description 17
- 230000000241 respiratory effect Effects 0.000 description 16
- 210000001736 capillary Anatomy 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 14
- 238000012030 stroop test Methods 0.000 description 13
- 230000000284 resting effect Effects 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 230000006461 physiological response Effects 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 210000003403 autonomic nervous system Anatomy 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 230000002889 sympathetic effect Effects 0.000 description 9
- 210000002565 arteriole Anatomy 0.000 description 8
- 238000005311 autocorrelation function Methods 0.000 description 8
- 238000004422 calculation algorithm Methods 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 210000003169 central nervous system Anatomy 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000010009 beating Methods 0.000 description 6
- 230000000747 cardiac effect Effects 0.000 description 6
- 210000000748 cardiovascular system Anatomy 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 230000001734 parasympathetic effect Effects 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 5
- 206010027940 Mood altered Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000004872 arterial blood pressure Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000000737 periodic effect Effects 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000005653 Brownian motion process Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 208000008784 apnea Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 238000005537 brownian motion Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 238000004378 air conditioning Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 230000035485 pulse pressure Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 230000008326 skin blood flow Effects 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 101100182136 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) loc-1 gene Proteins 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000037326 chronic stress Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 230000008921 facial expression Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009532 heart rate measurement Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000012623 in vivo measurement Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004298 light response Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000006855 networking Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000002746 orthostatic effect Effects 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000003938 response to stress Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 230000001457 vasomotor Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010050456 Anastomotic leak Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000007684 Occupational Stress Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 201000001718 Roberts syndrome Diseases 0.000 description 1
- 208000012474 Roberts-SC phocomelia syndrome Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 description 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037086 body physiology Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000037198 cardiovascular physiology Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011437 continuous method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007230 neural mechanism Effects 0.000 description 1
- 230000036403 neuro physiology Effects 0.000 description 1
- 230000007265 neurogenic response Effects 0.000 description 1
- 230000003705 neurological process Effects 0.000 description 1
- 230000004751 neurological system process Effects 0.000 description 1
- 238000012624 non-invasive in vivo measurement Methods 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000006388 psychological stress response Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 238000005001 rutherford backscattering spectroscopy Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Social Psychology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychology (AREA)
- Signal Processing (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Educational Technology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562249303P | 2015-11-01 | 2015-11-01 | |
| US62/249,303 | 2015-11-01 | ||
| US201662295138P | 2016-02-14 | 2016-02-14 | |
| US62/295,138 | 2016-02-14 | ||
| PCT/IB2016/001240 WO2017072568A1 (en) | 2015-11-01 | 2016-08-15 | Method and apparatus for hemodynamically characterizing a neurological or fitness state by dynamic light scattering (dls) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535745A JP2018535745A (ja) | 2018-12-06 |
| JP2018535745A5 JP2018535745A5 (enExample) | 2021-03-25 |
| JP6872758B2 true JP6872758B2 (ja) | 2021-05-19 |
Family
ID=58629842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521537A Active JP6872758B2 (ja) | 2015-11-01 | 2016-08-15 | 動的光散乱（ｄｌｓ）による神経学的状態又は適合性状態の血行力学的特徴付けのための方法及び装置 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10952622B2 (enExample) |
| EP (1) | EP3367893B1 (enExample) |
| JP (1) | JP6872758B2 (enExample) |
| WO (1) | WO2017072568A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3367893B1 (en) | 2015-11-01 | 2024-03-27 | Elfi-Tech Ltd. | Method and apparatus for hemodynamically characterizing a neurological or fitness state by dynamic light scattering (dls) |
| CN107348832B (zh) * | 2017-07-20 | 2020-03-20 | 吴联凯 | 一种基于最小蒸煮量的电饭锅以及其加热控制方法 |
| US11244452B2 (en) * | 2017-10-16 | 2022-02-08 | Massachusetts Institute Of Technology | Systems, devices and methods for non-invasive hematological measurements |
| CN108186018B (zh) * | 2017-11-23 | 2020-11-20 | 苏州朗开医疗技术有限公司 | 一种呼吸数据处理方法及装置 |
| US11647918B2 (en) | 2018-06-22 | 2023-05-16 | Siemens Healtchare GmbH | Method and diagnostic examination device for estimating an examination duration that is tolerable by a patient |
| US11617536B1 (en) * | 2019-01-31 | 2023-04-04 | Dartmouth-Hitchcock Clinic | System and method to measure pain levels of patients following surgery |
| WO2021015843A1 (en) | 2019-07-24 | 2021-01-28 | Massachusetts Institute Of Technology | Finger inserts for a nailfold imaging device |
| US20230053198A1 (en) * | 2021-02-24 | 2023-02-16 | Alexandria Brown SKALTSOUNIS | System and method for promoting, tracking, and assessing mental wellness |
| US11521715B2 (en) * | 2021-02-24 | 2022-12-06 | Alexandria Brown SKALTSOUNIS | System and method for promoting, tracking, and assessing mental wellness |
| US20230420111A1 (en) * | 2022-06-27 | 2023-12-28 | Izzy Justice | Computer device aided selection and administration of neurohacks |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6805673B2 (en) * | 2002-02-22 | 2004-10-19 | Datex-Ohmeda, Inc. | Monitoring mayer wave effects based on a photoplethysmographic signal |
| US20040082842A1 (en) * | 2002-10-28 | 2004-04-29 | Lumba Vijay K. | System for monitoring fetal status |
| US7020506B2 (en) | 2003-11-06 | 2006-03-28 | Orsense Ltd. | Method and system for non-invasive determination of blood-related parameters |
| US7758505B2 (en) | 2006-04-03 | 2010-07-20 | Elfi-Tech Ltd. | Methods and apparatus for non-invasive determination of patient's blood conditions |
| CA2655782A1 (en) | 2006-06-13 | 2007-12-21 | Elfi-Tech Ltd. | System and method for measurement of biological parameters of a subject |
| US20140094666A1 (en) * | 2012-09-28 | 2014-04-03 | Elfi-Tech Ltd. | System and method for in vivo measurement of biological parameters |
| EP2079363B1 (en) * | 2006-10-30 | 2020-06-10 | Elfi-Tech Ltd | Method for in vivo measurement of biological parameters |
| US20080255433A1 (en) * | 2007-04-11 | 2008-10-16 | The Board Of Regents Of The University Of Texas Syatem | Optoacoustic monitoring of multiple parameters |
| US8708907B2 (en) | 2009-05-06 | 2014-04-29 | Elfi-Tech | Method and apparatus for determining one or more blood parameters from analog electrical signals |
| US8868149B2 (en) * | 2009-07-30 | 2014-10-21 | Oxitone Medical Ltd. | Photoplethysmography device and method |
| US20110082355A1 (en) * | 2009-07-30 | 2011-04-07 | Oxitone Medical Ltd. | Photoplethysmography device and method |
| US20120130215A1 (en) | 2010-05-05 | 2012-05-24 | Ilya Fine | Optical measurement of parameters related to motion of light-scattering particles within a fluid by manipulating analog electrical signals |
| GB2494622A (en) | 2011-08-30 | 2013-03-20 | Oxitone Medical Ltd | Wearable pulse oximetry device |
| US9636025B2 (en) * | 2012-08-15 | 2017-05-02 | Nanyang Technological University | Systems and methods for pedal revascularization assessment |
| CN112716471A (zh) | 2013-08-14 | 2021-04-30 | 佩德拉科技私人有限公司 | 用于评估血管重建的系统和方法 |
| US20180153420A1 (en) * | 2013-09-30 | 2018-06-07 | Elfi-Tech Ltd. | Apparatus and method for optical measurement of cardiovascular fitness, stress and physiological parameters |
| US20150141766A1 (en) * | 2013-09-30 | 2015-05-21 | Flfi-Tfch Ltd. | Apparatus and method for optical measurement of cardiovascular recovery and/or repiration rate |
| EP3367893B1 (en) | 2015-11-01 | 2024-03-27 | Elfi-Tech Ltd. | Method and apparatus for hemodynamically characterizing a neurological or fitness state by dynamic light scattering (dls) |
| US11350837B2 (en) | 2016-03-30 | 2022-06-07 | Elfi-Tech Ltd. | Method and apparatus for optically measuring blood pressure |
| US11134901B2 (en) | 2016-03-30 | 2021-10-05 | Elfi-Tech Ltd. | Method and apparatus for optically measuring blood pressure |
| US10720755B2 (en) | 2018-02-07 | 2020-07-21 | Elfi-Tech Ltd. | Ensemble-averaged measurement of stochastic motion by current-modulating of VCSEL wavelength |
-
2016
- 2016-08-15 EP EP16859142.8A patent/EP3367893B1/en active Active
- 2016-08-15 JP JP2018521537A patent/JP6872758B2/ja active Active
- 2016-08-15 US US15/770,590 patent/US10952622B2/en active Active
- 2016-08-15 WO PCT/IB2016/001240 patent/WO2017072568A1/en not_active Ceased
-
2020
- 2020-08-13 US US16/992,157 patent/US11612328B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10952622B2 (en) | 2021-03-23 |
| EP3367893B1 (en) | 2024-03-27 |
| US11612328B2 (en) | 2023-03-28 |
| US20190008397A1 (en) | 2019-01-10 |
| US20210093204A1 (en) | 2021-04-01 |
| JP2018535745A (ja) | 2018-12-06 |
| EP3367893A4 (en) | 2019-11-13 |
| EP3367893A1 (en) | 2018-09-05 |
| WO2017072568A1 (en) | 2017-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6872758B2 (ja) | 動的光散乱（ｄｌｓ）による神経学的状態又は適合性状態の血行力学的特徴付けのための方法及び装置 | |
| US10687757B2 (en) | Psychological acute stress measurement using a wireless sensor | |
| Tschacher et al. | Physiological synchrony in audiences of live concerts. | |
| Deppe et al. | The investigation of functional brain lateralization by transcranial Doppler sonography | |
| Maxhuni et al. | Classification of bipolar disorder episodes based on analysis of voice and motor activity of patients | |
| ES2342056T3 (es) | Proceso de deteccion del estres por segmentacion y analisis de una señal de latidos de corazon. | |
| US10555677B2 (en) | Method and device for improving prediction and detection of change in a physiological condition | |
| Akbulut et al. | A smart wearable system for short-term cardiovascular risk assessment with emotional dynamics | |
| US20120116186A1 (en) | Method and apparatus for evaluation of a subject's emotional, physiological and/or physical state with the subject's physiological and/or acoustic data | |
| US20090192402A1 (en) | System and method providing biofeedback for anxiety and stress reduction | |
| WO2014063160A1 (en) | Detection of emotional states | |
| US20130184517A1 (en) | System and Method for Measuring and Controlling Stress | |
| KR20060037235A (ko) | 전기생리학적 직관 지시계 | |
| Fine et al. | A new sensor for stress measurement based on blood flow fluctuations | |
| Jong et al. | The PPG physiological signal for heart rate variability analysis | |
| Chauhan et al. | Real-time stress assessment through PPG sensor for VR biofeedback | |
| González et al. | Poincaré plot analysis of cerebral blood flow signals: Feature extraction and classification methods for apnea detection | |
| Soni et al. | A review on physiological signals: Heart rate variability and skin conductance | |
| RU2741934C2 (ru) | Устройство для выявления намерения, способ выявления намерения и программа для выявления намерения | |
| Khaksari et al. | Depth dependence of coherent hemodynamics in the human head | |
| Jaiswal et al. | Gsr based generic stress prediction system | |
| Pachori et al. | Biomedical engineering fundamentals | |
| Gandhi et al. | Mental stress assessment-a comparison between HRV based and respiration based techniques | |
| Zion et al. | Evaluation of blood pressure and baroreflex sensitivity by radial artery tonometry versus finger arteriolar photoplethysmography | |
| Dourou et al. | IoT-enabled analysis of subjective sound quality perception based on out-of-lab physiological measurements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20180713 Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20180713 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190805 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190805 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200722 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200811 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201109 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20210209 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210316 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210412 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6872758 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |